IL240753B - Methods for purifying antibodies - Google Patents
Methods for purifying antibodiesInfo
- Publication number
- IL240753B IL240753B IL240753A IL24075315A IL240753B IL 240753 B IL240753 B IL 240753B IL 240753 A IL240753 A IL 240753A IL 24075315 A IL24075315 A IL 24075315A IL 240753 B IL240753 B IL 240753B
- Authority
- IL
- Israel
- Prior art keywords
- purification methods
- antibody purification
- antibody
- methods
- purification
- Prior art date
Links
- 238000011091 antibody purification Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
- B01D15/3804—Affinity chromatography
- B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G or L chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Treatment Of Liquids With Adsorbents In General (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361787309P | 2013-03-15 | 2013-03-15 | |
| PCT/IB2014/059755 WO2014141150A1 (en) | 2013-03-15 | 2014-03-13 | Methods for purifying antibodies |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL240753A0 IL240753A0 (en) | 2015-10-29 |
| IL240753B true IL240753B (en) | 2021-01-31 |
Family
ID=50391244
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL240753A IL240753B (en) | 2013-03-15 | 2015-08-23 | Methods for purifying antibodies |
Country Status (15)
| Country | Link |
|---|---|
| US (3) | US10676503B2 (enExample) |
| EP (3) | EP3680000B1 (enExample) |
| JP (2) | JP6599773B2 (enExample) |
| KR (1) | KR102114021B1 (enExample) |
| CN (1) | CN105188872B (enExample) |
| AU (1) | AU2014229280B2 (enExample) |
| BR (1) | BR112015022321A2 (enExample) |
| CA (1) | CA2902287A1 (enExample) |
| DK (2) | DK3680000T3 (enExample) |
| ES (2) | ES2978309T3 (enExample) |
| IL (1) | IL240753B (enExample) |
| RU (1) | RU2651483C2 (enExample) |
| SG (1) | SG11201506494XA (enExample) |
| TW (1) | TWI625335B (enExample) |
| WO (1) | WO2014141150A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3680000B1 (en) | 2013-03-15 | 2024-03-13 | GlaxoSmithKline Intellectual Property Development Limited | Methods for purifying antibodies |
| CA2910065C (en) | 2013-05-15 | 2023-09-19 | Medimmune Limited | Purification of recombinantly produced polypeptides |
| EP3842108A1 (en) | 2014-04-30 | 2021-06-30 | Novo Nordisk A/S | Methods for the purification of proteins using caprylic acid |
| JP6663360B2 (ja) | 2015-01-26 | 2020-03-11 | 株式会社カネカ | 変異型免疫グロブリンκ鎖可変領域結合性ペプチド |
| WO2016121701A1 (ja) | 2015-01-26 | 2016-08-04 | 株式会社カネカ | 免疫グロブリンκ鎖可変領域含有タンパク質精製用アフィニティー分離マトリックス |
| WO2017195638A1 (ja) * | 2016-05-09 | 2017-11-16 | 株式会社カネカ | 抗体またはκ鎖可変領域含有抗体断片の精製方法 |
| EP4389757A3 (en) * | 2016-09-07 | 2025-01-01 | GlaxoSmithKline Intellectual Property Development Limited | Methods for purifying antibodies |
| CN106939045B (zh) * | 2017-05-01 | 2020-03-31 | 深圳市国创纳米抗体技术有限公司 | 一种单克隆抗体细胞培养液澄清的方法 |
| CN108085358A (zh) * | 2018-02-08 | 2018-05-29 | 保定冀中药业有限公司 | 一种犬细小病毒单克隆抗体IgG2b-Fab片段的制备方法 |
| TW202003555A (zh) | 2018-03-07 | 2020-01-16 | 英商葛蘭素史克智慧財產發展有限公司 | 用於純化重組多肽之方法 |
| TW202000891A (zh) | 2018-03-07 | 2020-01-01 | 英商葛蘭素史克智慧財產發展有限公司 | 純化抗體之方法 |
| JP2023539163A (ja) * | 2020-08-18 | 2023-09-13 | ザルトリウス ビーアイエー セパレーションズ ディー．オー．オー． | 宿主細胞ｄｎａの金属アフィニティー抽出 |
| CN114133446A (zh) * | 2021-12-31 | 2022-03-04 | 方坦思(上海)生物医药有限公司 | 单克隆抗体的纯化方法 |
| CN116179582A (zh) * | 2022-09-27 | 2023-05-30 | 南京医事达生物科技有限公司 | 一种通用型基因重组蛋白质a亲和纯化填料制备方法和应用 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005082937A2 (en) * | 2004-02-27 | 2005-09-09 | Octapharma Ag | A method of providing a purified, virus safe antibody preparation |
| WO2007109163A2 (en) * | 2006-03-16 | 2007-09-27 | Amgen Inc | Wash buffer and method of using |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57106673A (en) | 1980-12-24 | 1982-07-02 | Chugai Pharmaceut Co Ltd | Dibenzo(b,f)(1,4)oxazepin derivative |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| US5429746A (en) * | 1994-02-22 | 1995-07-04 | Smith Kline Beecham Corporation | Antibody purification |
| US6955917B2 (en) | 1997-06-20 | 2005-10-18 | Bayer Healthcare Llc | Chromatographic method for high yield purification and viral inactivation of antibodies |
| IL127127A0 (en) | 1998-11-18 | 1999-09-22 | Peptor Ltd | Small functional units of antibody heavy chain variable regions |
| DK2272378T3 (da) * | 2001-06-01 | 2014-10-06 | Upfront Chromatography As | Fraktionering af proteinholdige blandinger |
| DK1419179T3 (da) | 2001-08-10 | 2010-06-21 | Univ Aberdeen | Antigenbindingsdomæner fra fisk |
| WO2003102208A2 (en) | 2002-05-31 | 2003-12-11 | Indian Council Of Agricultural Research | Rapid detection of bt-cry toxins |
| JP2008500972A (ja) * | 2004-05-14 | 2008-01-17 | キリンファーマ株式会社 | 免疫グロブリンの精製方法 |
| AU2007292253A1 (en) | 2006-09-08 | 2008-03-13 | Wyeth | Arginine wash in protein purification using affinity chromatography |
| US20080167450A1 (en) * | 2007-01-05 | 2008-07-10 | Hai Pan | Methods of purifying proteins |
| WO2012135415A1 (en) | 2011-03-29 | 2012-10-04 | Glaxosmithkline Llc | Buffer system for protein purification |
| EP3680000B1 (en) | 2013-03-15 | 2024-03-13 | GlaxoSmithKline Intellectual Property Development Limited | Methods for purifying antibodies |
| CA2910065C (en) * | 2013-05-15 | 2023-09-19 | Medimmune Limited | Purification of recombinantly produced polypeptides |
| IL244149B2 (en) | 2013-09-13 | 2025-09-01 | Genentech Inc | Methods and compositions containing purified recombinant polypeptides |
-
2014
- 2014-03-13 EP EP19198005.1A patent/EP3680000B1/en active Active
- 2014-03-13 WO PCT/IB2014/059755 patent/WO2014141150A1/en not_active Ceased
- 2014-03-13 AU AU2014229280A patent/AU2014229280B2/en not_active Ceased
- 2014-03-13 CN CN201480016016.XA patent/CN105188872B/zh active Active
- 2014-03-13 DK DK19198005.1T patent/DK3680000T3/da active
- 2014-03-13 BR BR112015022321A patent/BR112015022321A2/pt not_active Application Discontinuation
- 2014-03-13 SG SG11201506494XA patent/SG11201506494XA/en unknown
- 2014-03-13 EP EP14713926.5A patent/EP2969098B1/en active Active
- 2014-03-13 TW TW103108898A patent/TWI625335B/zh active
- 2014-03-13 RU RU2015136860A patent/RU2651483C2/ru active
- 2014-03-13 JP JP2015562513A patent/JP6599773B2/ja active Active
- 2014-03-13 EP EP24155364.3A patent/EP4371996A3/en active Pending
- 2014-03-13 CA CA2902287A patent/CA2902287A1/en not_active Abandoned
- 2014-03-13 ES ES19198005T patent/ES2978309T3/es active Active
- 2014-03-13 US US14/775,868 patent/US10676503B2/en active Active
- 2014-03-13 DK DK14713926.5T patent/DK2969098T3/da active
- 2014-03-13 ES ES14713926T patent/ES2765206T3/es active Active
- 2014-03-13 KR KR1020157029042A patent/KR102114021B1/ko active Active
-
2015
- 2015-08-23 IL IL240753A patent/IL240753B/en active IP Right Grant
-
2019
- 2019-10-03 JP JP2019182562A patent/JP7002511B2/ja active Active
-
2020
- 2020-05-13 US US15/931,062 patent/US12358945B2/en active Active
-
2025
- 2025-06-12 US US19/235,815 patent/US20250353878A1/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005082937A2 (en) * | 2004-02-27 | 2005-09-09 | Octapharma Ag | A method of providing a purified, virus safe antibody preparation |
| WO2007109163A2 (en) * | 2006-03-16 | 2007-09-27 | Amgen Inc | Wash buffer and method of using |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3336106T3 (da) | Anti-fcrh5-antistoffer | |
| DK3708583T3 (da) | Ikke-fucosylerede anti-fgfr2iiib-antistoffer | |
| IL246002A0 (en) | Novel methods | |
| DK3613453T3 (da) | Fordamper | |
| DK3071595T3 (da) | Humaniseret anti-kallikrein-2-antistof | |
| IL240753B (en) | Methods for purifying antibodies | |
| DK2986722T3 (da) | Manipulerede phenylalaninammoniak-lyasepolypeptider | |
| DK3068800T3 (da) | FcRn-specifikke antistoffer | |
| DK3077047T3 (da) | Aramcholsalte | |
| DK3052081T3 (da) | Pastil | |
| DK3060460T3 (da) | Saddel | |
| DK3027598T3 (da) | Oxoquinazolinyl-butanamidderivater | |
| DK2956698T5 (da) | Bindestrimler | |
| DK2946640T3 (da) | Langmuir-probe | |
| EP2943489A4 (en) | DEUTERATED MOMELOTINIB | |
| DE102013106534B8 (de) | Chromatographiepipettenspitze | |
| DK3065774T3 (da) | Anti-CCL17-antistoffer | |
| EP2970310A4 (en) | 5-BROMO-indirubins | |
| EP2853297A4 (en) | kendama | |
| DK3071227T3 (da) | Fiskevaccine | |
| DE112014001252A5 (de) | Aufbissschiene | |
| DK3086679T3 (da) | Sportssko | |
| DK2981168T3 (da) | Laminitiskile | |
| FI10138U1 (fi) | Kelkkateltta | |
| ES1078715Y (es) | Mosquitera |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed |